Cargando…

Clinical efficacy of irinotecan plus raltitrexed chemotherapy in refractory esophageal squamous cell cancer

Our retrospective study assessed the efficacy and safety of irinotecan plus raltitrexed in esophageal squamous cell cancer (ESCC) patients who were previously treated with multiple systemic therapies. Between January 2016 and December 2018, records of 38 ESCC patients who underwent irinotecan plus r...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Min, Jia, Qingqing, Wang, Xiaolin, Sun, Changjiang, Yang, Jianqi, Chen, Yanliang, Li, Ying, Min, Lingfeng, Zhang, Xizhi, Zhu, Caiyun, Gubat, Johannes Artiaga, Chen, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077961/
https://www.ncbi.nlm.nih.gov/pubmed/31917701
http://dx.doi.org/10.1097/CAD.0000000000000891